Search

everythinglearnresearchcommunity

for

Search:↓

Dermatologists should carefully choose treatments for FFA to avoid worsening the condition.

Folate receptor β helps suppress the immune system in macrophages and affects cancer growth and hair health.

sFRP4 partially inhibits hair regeneration, but the study needs clearer data analysis and better explanation of the process.

Early diagnosis and treatment of frontal fibrosing alopecia are crucial to prevent permanent hair loss.

The cause of Frontal fibrosing alopecia, a type of hair loss, is complex, likely involving immune responses and genetics, but is not fully understood.

Frontal Fibrosing Alopecia is a hair loss condition mainly affecting postmenopausal women, with unclear causes and various clinical patterns.

Frontal fibrosing alopecia is a scarring hair loss condition mainly affecting older women, with no known cause and treatments that may help stabilize hair loss.

Cosmetic treatments can replenish key amino acids in damaged hair, improving its strength and appearance.

FFA is more common in postmenopausal women, can affect younger women, and may stabilize over time.

Frontal fibrosing alopecia mostly affects postmenopausal women, with diagnosis often delayed by 3 years.

Radiofrequency treatment helps rejuvenate skin by boosting collagen and blood vessel growth.

Frontal fibrosing alopecia is increasing, especially in postmenopausal women, and treatment with finasteride can improve it.

Frontal fibrosing alopecia may be caused by an autoimmune reaction and hormonal imbalance.

A protein called sFRP4 can partly inhibit hair growth.

Frontal Fibrosing Alopecia is a poorly understood condition that is hard to treat and causes distressing hair loss.

Radiation treatment causes skin fibrosis by increasing certain fibroblast subpopulations, but using a c-Jun inhibitor or fat grafting can reduce this effect.

Frontal fibrosing alopecia is a scarring hair loss condition mainly affecting postmenopausal women, with unclear causes.

FGF-9 speeds up the early development of certain organs, showing potential for organ regeneration.

Sfrp2 increases during hair follicle catagen phase and slows keratinocyte growth.

GRF is not safe for tubal occlusion.

Facial feminization surgery is effective in helping transgender women appear more feminine and has high patient satisfaction.

A specific gene variation in goats is linked to better growth traits.

The research suggests that SFRP2 and PTGDS proteins might be indicators of female pattern hair loss and could contribute to hair loss.

Hair transplantation may not work for Frontal Fibrosing Alopecia as transplanted hair was lost when the disease came back.

FRMS is a safe and effective treatment for acne scars in Asians with minimal side effects.

Researchers created a new mouse model, G4, that mimics human PCOS symptoms and links the condition to a specific gene.

bFGF delays hair growth in mice.

GLI2 increases follistatin production in human skin cells.

GFC injections significantly improved hair growth and quality with minimal side effects.

SFRP2 and PTGDS may be key factors in female hair loss.